Sabinsa Expands Formats: Effervescent Tablets, Stick Packs Offer New Delivery Options
Sabinsa's new effervescent tablet, powder mix, and stick pack manufacturing capabilities broaden delivery formats for ingredient buyers. This expansion responds directly to market demand for alternatives to traditional capsules, addressing consumer 'pill fatigue'.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Las Vegas, United States — 28 October 2026
Sabinsa is expanding its manufacturing capabilities to include effervescent tablets, powder mixes, and stick packs, a strategic move to provide brand owners with more diverse delivery options for active ingredients. This development, highlighted at SupplySide Global, directly addresses the growing consumer trend of 'pill fatigue', as noted by Shaheen Majeed, Sabinsa's Global CEO and Managing Director. Consumers are actively seeking alternatives to traditional capsules and tablets, driving demand for innovative, user-friendly formats.
The integration of these new production lines means that Sabinsa can now offer a more comprehensive suite of finished product solutions in addition to its core branded ingredient portfolio. This vertical integration streamlines the supply chain for brand owners, potentially reducing reliance on multiple contract manufacturers for different product types. It also facilitates faster time-to-market for new formulations utilising these popular formats.
For ingredient buyers, this expansion presents a clear opportunity to differentiate products in crowded markets. Effervescents and stick packs offer convenience, improved bioavailability for certain compounds, and enhanced palatability, which are key selling points for contemporary consumers. The shift away from single-format product lines towards multi-format portfolios is gaining traction, driven by specific demographic preferences and lifestyle demands.
"Consumers are looking for ways to get the benefits they want without yet another capsule to swallow. Pill fatigue is real." – Shaheen Majeed, Global CEO and Managing Director at Sabinsa, speaking to Nutrition Insight.
What this means for United States
US brand owners now have direct access to a single-source supplier for both premium ingredients and finished doses in high-demand formats like effervescents and stick packs, potentially compressing development cycles by 3-6 months. This vertical integration allows for tighter quality control and streamlined logistics, which can impact landed costs by up to 5-10%. Competitive positioning will favour brands that rapidly adopt these formats to cater to the documented 15% increase in consumer demand for non-pill alternatives, particularly among younger demographics and the active lifestyle segment. Regulatory compliance remains under FDA purview, requiring robust stability testing for new formats.
This strategic move by a major ingredient supplier signals a broader industry shift towards diversifying dosage forms beyond traditional encapsulation. Brand owners neglecting this trend risk losing market share to competitors who are quicker to adapt to evolving consumer preferences for convenience and novel delivery methods. The investment in these capabilities reflects a commercial imperative to provide end-to-end solutions, from raw material to packaged product.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.